Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults

Jacqueline Cloos; Angèle Kelder; Gert J. Ossenkoppele; Gerrit J. Schuurhuis; on behalf of the UK NCRI AML Trial Group; on behalf of the HOVON AML Trial Group

doi:10.1111/bjh.15698

Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults

Jacqueline Cloos, Angèle Kelder, Gert J. Ossenkoppele, Gerrit J. Schuurhuis, on behalf of the UK NCRI AML Trial Group, on behalf of the HOVON AML Trial Group

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	130-133
Journal	British Journal of Haematology
Volume	186
Issue number	1
DOIs	https://doi.org/10.1111/bjh.15698
Publication status	Published - 1 Jul 2019

Access to Document

10.1111/bjh.15698

Link to publication in Scopus

Cite this

Cloos, J., Kelder, A., Ossenkoppele, G. J., Schuurhuis, G. J., on behalf of the UK NCRI AML Trial Group, & on behalf of the HOVON AML Trial Group (2019). Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults. British Journal of Haematology, 186(1), 130-133. https://doi.org/10.1111/bjh.15698

Cloos, Jacqueline ; Kelder, Angèle ; Ossenkoppele, Gert J. ; Schuurhuis, Gerrit J. ; on behalf of the UK NCRI AML Trial Group ; on behalf of the HOVON AML Trial Group. / Induction response criteria in acute myeloid leukaemia : implications of a flow cytometric measurable residual disease negative test in refractory adults. In: British Journal of Haematology. 2019 ; Vol. 186, No. 1. pp. 130-133.

@article{dc00348d96fb43af89de3a3896a73ef8,

title = "Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults",

keywords = "acute leukaemia, flow cytometry, measurable residual disease",

author = "Freeman, {Sylvie D.} and Hills, {Robert K.} and Russell, {Nigel H.} and Jacqueline Cloos and Ang{\`e}le Kelder and Ossenkoppele, {Gert J.} and Schuurhuis, {Gerrit J.} and {on behalf of the UK NCRI AML Trial Group} and {on behalf of the HOVON AML Trial Group}",

year = "2019",

month = jul,

day = "1",

doi = "10.1111/bjh.15698",

language = "English",

volume = "186",

pages = "130--133",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

number = "1",

}

Cloos, J, Kelder, A, Ossenkoppele, GJ , Schuurhuis, GJ, on behalf of the UK NCRI AML Trial Group & on behalf of the HOVON AML Trial Group 2019, 'Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults', British Journal of Haematology, vol. 186, no. 1, pp. 130-133. https://doi.org/10.1111/bjh.15698

Induction response criteria in acute myeloid leukaemia : implications of a flow cytometric measurable residual disease negative test in refractory adults. / Cloos, Jacqueline; Kelder, Angèle; Ossenkoppele, Gert J.; Schuurhuis, Gerrit J.; on behalf of the UK NCRI AML Trial Group; on behalf of the HOVON AML Trial Group.

In: British Journal of Haematology, Vol. 186, No. 1, 01.07.2019, p. 130-133.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Induction response criteria in acute myeloid leukaemia

T2 - implications of a flow cytometric measurable residual disease negative test in refractory adults

AU - Freeman, Sylvie D.

AU - Hills, Robert K.

AU - Russell, Nigel H.

AU - Cloos, Jacqueline

AU - Kelder, Angèle

AU - Ossenkoppele, Gert J.

AU - Schuurhuis, Gerrit J.

AU - on behalf of the UK NCRI AML Trial Group

AU - on behalf of the HOVON AML Trial Group

PY - 2019/7/1

Y1 - 2019/7/1

KW - acute leukaemia

KW - flow cytometry

KW - measurable residual disease

UR - http://www.scopus.com/inward/record.url?scp=85057739245&partnerID=8YFLogxK

U2 - 10.1111/bjh.15698

DO - 10.1111/bjh.15698

M3 - Letter

C2 - 30520018

AN - SCOPUS:85057739245

VL - 186

SP - 130

EP - 133

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 1

ER -

Cloos J, Kelder A, Ossenkoppele GJ , Schuurhuis GJ, on behalf of the UK NCRI AML Trial Group, on behalf of the HOVON AML Trial Group. Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults. British Journal of Haematology. 2019 Jul 1;186(1):130-133. https://doi.org/10.1111/bjh.15698